Documents & Downloads
You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)
Performance
30 Day Daily Return
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.
Total Return
Month-End Total Returns as of 10/31/2024
| Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|
| BIB Market Price | -5.65% | -9.72% | 20.07% | 6.26% | 45.93% | -12.62% | 4.32% | 0.00% | 15.45% | 04/07/2010 |
| BIB NAV | -5.52% | -9.53% | 20.43% | 6.34% | 46.24% | -12.56% | 4.33% | 0.03% | 15.46% | 04/07/2010 |
| Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|
| BIB Market Price | -5.12% | 7.86% | 11.58% | 12.62% | 34.03% | -12.17% | 8.62% | 2.15% | 16.01% | 04/07/2010 |
| BIB NAV | -5.08% | 7.92% | 11.63% | 12.55% | 33.84% | -12.12% | 8.61% | 2.17% | 16.01% | 04/07/2010 |
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.
About the Fund
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Gross Expense Ratio 1.14%
- Net Expense Ratio 0.95%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 11/20/2024- NAV $54.45
- NAV Change $+0.78
- Market Price $54.31
- Market Price Change $+0.79
- Trading Volume (M) 8,546
- 30-Day Median Bid Ask Spread 0.24%
- View Premium / Discount
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Expense Ratio 0.95%
- Gross Expense Ratio 1.14%
- NAV Calculation Time 4:00 p.m. ET
Price
as of 11/20/2024- NAV $54.45
- NAV Change $+0.78
- Market Price $54.31
- Market Price Change $+0.79
- Trading Volume (M) 8,546
- 30-Day Median Bid Ask Spread 0.24%
- View Premium / Discount
Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.
Exposures
Index as of 9/30/2024
Holdings
as of 11/20/2024
| Exposure Weight | Ticker | Description | Exposure Value (Notional + GL) |
Market Value | Shares/Contracts | SEDOL Number |
|---|---|---|---|---|---|---|
| 42.41% | -- | NASDAQ BIO INDEX SWAP BNP PARIBAS | 30,480,587 | -- | 6,873 | -- |
| 30.40% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 21,850,407 | -- | 4,927 | -- |
| 27.81% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 19,987,779 | -- | 4,507 | -- |
| 8.15% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 5,858,410 | -- | 1,321 | -- |
| 7.37% | GILD | GILEAD SCIENCES INC | -- | $5,295,376.61 | 59,747 | 2369174 |
| 6.42% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 4,616,658 | -- | 1,041 | -- |
| 5.98% | VRTX | VERTEX PHARMACEUTICALS INC | -- | $4,295,709.60 | 9,520 | 2931034 |
| 5.66% | AMGN | AMGEN INC | -- | $4,069,618.19 | 14,137 | 2023607 |
| 5.47% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 3,929,259 | -- | 886 | -- |
| 4.21% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC | 3,028,989 | -- | 683 | -- |
| 4.12% | REGN | REGENERON PHARMACEUTICALS | -- | $2,962,993.10 | 3,986 | 2730190 |
| 2.93% | AZN | ASTRAZENECA PLC-SPONS ADR | -- | $2,106,076.80 | 33,324 | 2989044 |
| 2.54% | ALNY | ALNYLAM PHARMACEUTICALS INC | -- | $1,827,611.34 | 7,346 | B00FWN1 |
| 1.81% | BIIB | BIOGEN INC | -- | $1,299,792.00 | 8,332 | 2455965 |
| 1.67% | ILMN | ILLUMINA INC | -- | $1,200,526.56 | 9,117 | 2613990 |
| 1.51% | ARGX | ARGENX SE - ADR | -- | $1,087,173.34 | 1,837 | BDVLM39 |
| 1.29% | UTHR | UNITED THERAPEUTICS CORP | -- | $927,584.18 | 2,546 | 2430412 |
| 1.25% | VTRS | VIATRIS INC | -- | $896,779.00 | 68,300 | BMWS3X9 |
| 1.13% | MRNA | MODERNA INC | -- | $812,606.12 | 21,998 | BGSXTS3 |
| 1.11% | SNY | SANOFI-ADR | -- | $799,359.40 | 16,730 | 2964557 |
| 1.09% | INCY | INCYTE CORP | -- | $782,971.00 | 11,020 | 2471950 |
| 1.07% | SMMT | SUMMIT THERAPEUTICS INC | -- | $771,947.96 | 41,458 | BMTVQS7 |
| 0.99% | INSM | INSMED INC | -- | $714,636.78 | 9,834 | 2614487 |
| 0.99% | NBIX | NEUROCRINE BIOSCIENCES INC | -- | $712,492.91 | 5,779 | 2623911 |
| 0.95% | BMRN | BIOMARIN PHARMACEUTICAL INC | -- | $681,653.76 | 10,896 | 2437071 |
| 0.94% | RPRX | ROYALTY PHARMA PLC- CL A | -- | $672,307.02 | 25,641 | BMVP7Y0 |
| 0.84% | SRPT | SAREPTA THERAPEUTICS INC | -- | $605,184.74 | 5,459 | B8DPDT7 |
| 0.81% | MEDP | MEDPACE HOLDINGS INC | -- | $579,135.84 | 1,776 | BDCBC61 |
| 0.80% | BNTX | BIONTECH SE-ADR | -- | $573,005.40 | 5,610 | BK6H543 |
| 0.79% | EXEL | EXELIXIS INC | -- | $565,695.90 | 16,326 | 2576941 |
| 0.76% | PCVX | VAXCYTE INC | -- | $549,112.48 | 6,388 | BKPVGH6 |
| 0.76% | RVMD | REVOLUTION MEDICINES INC | -- | $545,532.13 | 9,559 | BL71K91 |
| 0.72% | ITCI | INTRA-CELLULAR THERAPIES INC | -- | $517,779.44 | 6,046 | BHCB0P4 |
| 0.68% | BGNE | BEIGENE LTD-ADR | -- | $491,089.28 | 2,528 | BYYWPW6 |
| 0.68% | ROIV | ROIVANT SCIENCES LTD | -- | $486,222.33 | 42,317 | BMW4NZ9 |
| 0.59% | JAZZ | JAZZ PHARMACEUTICALS PLC | -- | $421,394.16 | 3,534 | B4Q5ZN4 |
| 0.57% | ASND | ASCENDIS PHARMA A/S - ADR | -- | $412,444.08 | 3,316 | BV9G6B8 |
| 0.55% | MDGL | MADRIGAL PHARMACEUTICALS INC | -- | $392,874.51 | 1,239 | BD59BS7 |
| 0.48% | BPMC | BLUEPRINT MEDICINES CORP | -- | $343,875.87 | 3,627 | BWY52P3 |
| 0.47% | CYTK | CYTOKINETICS INC | -- | $335,707.38 | 6,733 | BBBSBJ5 |
| 0.46% | HALO | HALOZYME THERAPEUTICS INC | -- | $331,714.24 | 7,249 | 2975098 |
| 0.43% | NUVL | NUVALENT INC-A | -- | $309,613.32 | 3,396 | BMVBZD3 |
| 0.41% | IONS | IONIS PHARMACEUTICALS INC | -- | $296,191.80 | 8,367 | BDJ0LS6 |
| 0.41% | KRYS | KRYSTAL BIOTECH INC | -- | $292,618.30 | 1,643 | BD6JX35 |
| 0.41% | RNA | AVIDITY BIOSCIENCES INC | -- | $292,498.65 | 6,701 | BMWHPY1 |
| 0.40% | ADMA | ADMA BIOLOGICS INC | -- | $285,054.43 | 13,339 | B9NSBM2 |
| 0.37% | ACLX | ARCELLX INC | -- | $268,375.94 | 3,077 | BPCJ1Q2 |
| 0.37% | ALKS | ALKERMES PLC | -- | $263,051.75 | 9,425 | B3P6D26 |
| 0.36% | AXSM | AXSOME THERAPEUTICS INC | -- | $259,866.20 | 2,747 | BYZR4X4 |
| 0.36% | CRNX | CRINETICS PHARMACEUTICALS IN | -- | $256,800.60 | 4,580 | BDD19F8 |
| 0.34% | BBIO | BRIDGEBIO PHARMA INC | -- | $247,933.44 | 10,761 | BK1KWG8 |
| 0.34% | RARE | ULTRAGENYX PHARMACEUTICAL IN | -- | $244,760.00 | 5,275 | BJ62Z18 |
| 0.32% | CRSP | CRISPR THERAPEUTICS AG | -- | $230,297.98 | 4,873 | BDHF4K6 |
| 0.30% | IMVT | IMMUNOVANT INC | -- | $219,226.09 | 8,377 | BJRFSB7 |
| 0.30% | GH | GUARDANT HEALTH INC | -- | $215,864.48 | 7,036 | BFXC911 |
| 0.29% | RYTM | RHYTHM PHARMACEUTICALS INC | -- | $207,641.28 | 3,498 | BF2YWG4 |
| 0.28% | DNLI | DENALI THERAPEUTICS INC | -- | $200,073.06 | 8,193 | BD2B4V0 |
| 0.27% | IBRX | IMMUNITYBIO INC | -- | $194,322.38 | 39,861 | BNSP0B8 |
| 0.27% | APLS | APELLIS PHARMACEUTICALS INC | -- | $191,577.81 | 6,969 | BYTQ6X1 |
| 0.26% | LEGN | LEGEND BIOTECH CORP-ADR | -- | $187,614.36 | 4,674 | BMX9K07 |
| 0.26% | PTCT | PTC THERAPEUTICS INC | -- | $184,707.92 | 4,402 | B17VCN9 |
| 0.25% | AGIO | AGIOS PHARMACEUTICALS INC | -- | $177,842.72 | 3,256 | BCBVTX1 |
| 0.24% | DYN | DYNE THERAPEUTICS INC | -- | $172,382.52 | 5,748 | BN15WD1 |
| 0.24% | VCYT | VERACYTE INC | -- | $172,284.00 | 4,395 | BFTWZY0 |
| 0.24% | EWTX | EDGEWISE THERAPEUTICS INC | -- | $171,475.65 | 5,367 | BKY5JZ8 |
| 0.24% | XENE | XENON PHARMACEUTICALS INC | -- | $170,617.58 | 4,337 | BRJ3GY4 |
| 0.23% | MRUS | MERUS NV | -- | $167,641.65 | 3,905 | BZBY005 |
| 0.23% | KYMR | KYMERA THERAPEUTICS INC | -- | $162,852.85 | 3,697 | BMPRZV5 |
| 0.23% | FOLD | AMICUS THERAPEUTICS INC | -- | $162,723.12 | 16,968 | B19FQ48 |
| 0.22% | VRNA | VERONA PHARMA PLC - ADR | -- | $160,450.50 | 4,130 | BYWPZK5 |
| 0.22% | VCEL | VERICEL CORP | -- | $160,385.26 | 2,801 | BSBMN89 |
| 0.22% | SWTX | SPRINGWORKS THERAPEUTICS INC | -- | $159,157.44 | 4,251 | BGMGM89 |
| 0.21% | ACAD | ACADIA PHARMACEUTICALS INC | -- | $154,451.11 | 9,493 | 2713317 |
| 0.20% | JANX | JANUX THERAPEUTICS INC | -- | $146,194.56 | 2,986 | BMFX8Y7 |
| 0.20% | VERA | VERA THERAPEUTICS INC | -- | $143,563.50 | 3,138 | BL55460 |
| 0.20% | IOVA | IOVANCE BIOTHERAPEUTICS INC | -- | $141,383.66 | 17,369 | BF0DMK7 |
| 0.19% | TWST | TWIST BIOSCIENCE CORP | -- | $137,924.05 | 3,355 | BGKG6G7 |
| 0.19% | GERN | GERON CORP | -- | $137,631.06 | 34,494 | 2370381 |
| 0.19% | PTGX | PROTAGONIST THERAPEUTICS INC | -- | $136,990.50 | 3,370 | BDCBCD8 |
| 0.19% | ARWR | ARROWHEAD PHARMACEUTICALS IN | -- | $133,140.36 | 7,116 | BYQBFJ8 |
| 0.18% | SRRK | SCHOLAR ROCK HOLDING CORP | -- | $127,598.80 | 4,580 | BFZQ0L8 |
| 0.17% | IDYA | IDEAYA BIOSCIENCES INC | -- | $123,332.66 | 4,829 | BK0VHF6 |
| 0.17% | AMPH | AMPHASTAR PHARMACEUTICALS IN | -- | $122,878.83 | 2,787 | BNFWZS4 |
| 0.17% | AKRO | AKERO THERAPEUTICS INC | -- | $121,743.49 | 3,974 | BK7Y2V9 |
| 0.17% | MIRM | MIRUM PHARMACEUTICALS INC | -- | $119,186.32 | 2,728 | BJDX8Y8 |
| 0.16% | LGND | LIGAND PHARMACEUTICALS | -- | $116,691.76 | 1,046 | 2501578 |
| 0.16% | KROS | KEROS THERAPEUTICS INC | -- | $116,292.72 | 2,148 | BM7V485 |
| 0.16% | APGE | APOGEE THERAPEUTICS INC | -- | $116,023.04 | 2,576 | BM9HHL5 |
| 0.16% | BEAM | BEAM THERAPEUTICS INC | -- | $115,543.82 | 4,718 | BK6L288 |
| 0.16% | SUPN | SUPERNUS PHARMACEUTICALS INC | -- | $113,922.48 | 3,154 | B72ZBG4 |
| 0.16% | GPCR | STRUCTURE THERAPEUTICS INC | -- | $111,541.10 | 3,410 | BQS9486 |
| 0.15% | RXRX | RECURSION PHARMACEUTICALS-A | -- | $108,375.67 | 17,943 | BM9FJ13 |
| 0.15% | MNKD | MANNKIND CORP | -- | $108,270.56 | 15,737 | BF081J4 |
| 0.15% | HRMY | HARMONY BIOSCIENCES HOLDINGS | -- | $106,665.87 | 3,253 | BKSGZN7 |
| 0.15% | IRON | DISC MEDICINE INC | -- | $106,522.65 | 1,703 | BMGJZJ8 |
| 0.15% | NVCR | NOVOCURE LTD | -- | $104,430.84 | 6,194 | BYSS4X4 |
| 0.14% | WVE | WAVE LIFE SCIENCES LTD | -- | $101,730.84 | 7,134 | BYZG9R0 |
| 0.14% | TARS | TARSUS PHARMACEUTICALS INC | -- | $101,358.08 | 2,176 | BMH5RL1 |
| 0.14% | FTRE | FORTREA HOLDINGS INC | -- | $98,162.90 | 5,126 | BRXYZ57 |
| 0.13% | DVAX | DYNAVAX TECHNOLOGIES CORP | -- | $91,214.15 | 7,495 | BRJZSK0 |
| 0.12% | ARVN | ARVINAS INC | -- | $89,103.63 | 3,927 | BDZ30Q0 |
| 0.12% | BCRX | BIOCRYST PHARMACEUTICALS INC | -- | $86,417.40 | 11,838 | 2100362 |
| 0.12% | HROW | HARROW INC | -- | $86,153.20 | 2,030 | BHNDW86 |
| 0.12% | XNCR | XENCOR INC | -- | $83,945.08 | 3,539 | BGCYWN8 |
| 0.12% | NRIX | NURIX THERAPEUTICS INC | -- | $83,451.04 | 3,686 | BMVLGP2 |
| 0.11% | MYGN | MYRIAD GENETICS INC | -- | $79,544.70 | 5,199 | 2614153 |
| 0.11% | OCUL | OCULAR THERAPEUTIX INC | -- | $78,343.94 | 8,923 | BNZB1X8 |
| 0.11% | TVTX | TRAVERE THERAPEUTICS INC | -- | $78,137.50 | 4,375 | BLFGJD5 |
| 0.11% | DAWN | DAY ONE BIOPHARMACEUTICALS I | -- | $77,811.06 | 5,713 | BLB0YH0 |
| 0.11% | SNDX | SYNDAX PHARMACEUTICALS INC | -- | $77,660.55 | 4,869 | BN7Q7R7 |
| 0.11% | NTLA | INTELLIA THERAPEUTICS INC | -- | $76,279.68 | 5,814 | BYZM6C2 |
| 0.10% | SPRY | ARS PHARMACEUTICALS INC | -- | $75,175.40 | 5,548 | BMCR7V2 |
| 0.10% | ZLAB | ZAI LAB LTD-ADR | -- | $74,598.12 | 2,844 | BD9GVY0 |
| 0.10% | NVAX | NOVAVAX INC | -- | $73,805.42 | 9,157 | BJDQXG4 |
| 0.10% | IMCR | IMMUNOCORE HOLDINGS PLC-ADR | -- | $71,713.04 | 2,212 | BLCD809 |
| 0.10% | KURA | KURA ONCOLOGY INC | -- | $69,749.44 | 4,384 | BYZD465 |
| 0.10% | ELVN | ENLIVEN THERAPEUTICS INC | -- | $68,762.72 | 2,704 | BMFD115 |
| 0.10% | INVA | INNOVIVA INC | -- | $68,557.00 | 3,580 | BDDXF67 |
| 0.09% | ARQT | ARCUTIS BIOTHERAPEUTICS INC | -- | $68,094.02 | 6,689 | BKX9VD3 |
| 0.09% | RCKT | ROCKET PHARMACEUTICALS INC | -- | $67,912.32 | 5,208 | BDFKQ07 |
| 0.09% | CNTA | CENTESSA PHARMACEUTICALS-ADR | -- | $67,713.30 | 4,045 | BLB0YQ9 |
| 0.09% | AUPH | AURINIA PHARMACEUTICALS INC | -- | $67,419.68 | 8,182 | BFWLC09 |
| 0.09% | ANIP | ANI PHARMACEUTICALS INC | -- | $66,340.40 | 1,204 | BCDWBX6 |
| 0.09% | ARDX | ARDELYX INC | -- | $66,297.00 | 13,475 | BN89V40 |
| 0.08% | GRFS | GRIFOLS SA-ADR | -- | $60,028.00 | 6,980 | B8K7T65 |
| 0.08% | AVDL | AVADEL PHARMACEUTICALS | -- | $59,211.00 | 5,508 | BDGMC59 |
| 0.08% | ZYME | ZYMEWORKS INC | -- | $59,160.30 | 4,066 | BPCQZY9 |
| 0.08% | COGT | COGENT BIOSCIENCES INC | -- | $56,877.12 | 6,264 | BLR6XK8 |
| 0.08% | COLL | COLLEGIUM PHARMACEUTICAL INC | -- | $55,320.00 | 1,844 | BX7RSN3 |
| 0.07% | VIR | VIR BIOTECHNOLOGY INC | -- | $52,706.80 | 7,820 | BK4PZ38 |
| 0.07% | KNSA | KINIKSA PHARMACEUTICALS INTE | -- | $49,313.25 | 2,325 | BRXB0C0 |
| 0.07% | GMAB | GENMAB A/S -SP ADR | -- | $49,080.00 | 2,400 | BBC9WC7 |
| 0.07% | ETNB | 89BIO INC | -- | $48,366.78 | 6,061 | BK1K484 |
| 0.06% | EOLS | EVOLUS INC | -- | $45,606.93 | 3,611 | BDRJH21 |
| 0.06% | CSTL | CASTLE BIOSCIENCES INC | -- | $45,178.60 | 1,588 | BKLCWZ3 |
| 0.06% | ABCL | ABCELLERA BIOLOGICS INC | -- | $45,024.21 | 16,863 | BL53SR3 |
| 0.06% | PCRX | PACIRA BIOSCIENCES INC | -- | $44,942.17 | 2,639 | B3X26D8 |
| 0.06% | PRTA | PROTHENA CORP PLC | -- | $44,323.20 | 3,078 | B91XRN2 |
| 0.06% | PLRX | PLIANT THERAPEUTICS INC | -- | $44,287.67 | 3,479 | BMDWW66 |
| 0.06% | REPL | REPLIMUNE GROUP INC | -- | $43,864.38 | 3,906 | BDDVW37 |
| 0.06% | BCYC | BICYCLE THERAPEUTICS PLC-ADR | -- | $43,265.00 | 2,125 | BKDQKM6 |
| 0.06% | ERAS | ERASCA INC | -- | $42,670.32 | 16,163 | BNLYBF3 |
| 0.06% | CGEM | CULLINAN THERAPEUTICS INC | -- | $41,753.02 | 3,319 | BM90J52 |
| 0.06% | AVXL | ANAVEX LIFE SCIENCES CORP | -- | $41,120.70 | 4,852 | BYTYP72 |
| 0.05% | MRVI | MARAVAI LIFESCIENCES HLDGS-A | -- | $39,051.64 | 8,102 | BMCWKZ2 |
| 0.05% | ADPT | ADAPTIVE BIOTECHNOLOGIES | -- | $37,300.38 | 8,439 | BJ5FZ74 |
| 0.05% | ABUS | ARBUTUS BIOPHARMA CORP | -- | $37,169.20 | 10,805 | BZ0QMB7 |
| 0.05% | MLYS | MINERALYS THERAPEUTICS INC | -- | $35,847.00 | 2,845 | BP9N0G0 |
| 0.05% | RLAY | RELAY THERAPEUTICS INC | -- | $35,709.58 | 7,663 | BN2R582 |
| 0.05% | ORIC | ORIC PHARMACEUTICALS INC | -- | $35,274.64 | 4,036 | BKVDFF7 |
| 0.05% | TRML | TOURMALINE BIO INC | -- | $35,208.00 | 1,467 | BQ80NC6 |
| 0.05% | ANAB | ANAPTYSBIO INC | -- | $35,095.68 | 1,728 | BDRW1L7 |
| 0.05% | PHAT | PHATHOM PHARMACEUTICALS INC | -- | $34,134.30 | 3,910 | BJLKVS6 |
| 0.04% | SANA | SANA BIOTECHNOLOGY INC | -- | $32,214.49 | 12,733 | BMFJJ97 |
| 0.04% | IRWD | IRONWOOD PHARMACEUTICALS INC | -- | $32,183.36 | 9,143 | B3MZ6K5 |
| 0.04% | AUTL | AUTOLUS THERAPEUTICS PLC | -- | $31,987.20 | 11,424 | BFMLGR4 |
| 0.04% | CVAC | CUREVAC NV | -- | $31,954.17 | 12,833 | BN4RD42 |
| 0.04% | HCM | HUTCHMED CHINA-ADR | -- | $31,914.92 | 1,777 | BYXV9H7 |
| 0.04% | HUMA | HUMACYTE INC | -- | $30,124.71 | 6,831 | BMYTJP4 |
| 0.04% | GLPG | GALAPAGOS NV-SPON ADR | -- | $29,716.76 | 1,159 | B292NQ7 |
| 0.04% | SVRA | SAVARA INC | -- | $29,487.73 | 9,421 | BYXGN81 |
| 0.04% | EYPT | EYEPOINT PHARMACEUTICALS INC | -- | $28,217.21 | 3,151 | BMGS7L1 |
| 0.04% | TBPH | THERAVANCE BIOPHARMA INC | -- | $27,916.00 | 2,800 | BMNDK09 |
| 0.04% | URGN | UROGEN PHARMA LTD | -- | $27,594.50 | 2,410 | BZ7PJQ1 |
| 0.04% | THRD | THIRD HARMONIC BIO INC | -- | $27,307.00 | 2,350 | BNNPQY8 |
| 0.04% | RGNX | REGENXBIO INC | -- | $27,233.64 | 2,828 | BZ0G875 |
| 0.04% | PAHC | PHIBRO ANIMAL HEALTH CORP-A | -- | $27,202.57 | 1,163 | BL95N25 |
| 0.04% | OLMA | OLEMA PHARMACEUTICALS INC | -- | $27,125.28 | 3,276 | BMZ4LN0 |
| 0.04% | YMAB | Y-MABS THERAPEUTICS INC | -- | $26,866.46 | 2,549 | BG31GH0 |
| 0.04% | PACB | PACIFIC BIOSCIENCES OF CALIF | -- | $26,816.52 | 15,591 | B4N8MH9 |
| 0.04% | GRAL | GRAIL INC | -- | $26,814.93 | 1,777 | BSLSSX7 |
| 0.04% | OABI | OMNIAB INC | -- | $26,356.20 | 6,758 | BN13S71 |
| 0.04% | XERS | XERIS BIOPHARMA HOLDINGS INC | -- | $26,086.50 | 8,525 | BLR7H87 |
| 0.04% | MGTX | MEIRAGTX HOLDINGS PLC | -- | $25,782.60 | 4,430 | BFYQFJ2 |
| 0.04% | SIGA | SIGA TECHNOLOGIES INC | -- | $25,537.50 | 4,086 | 2107437 |
| 0.04% | SLRN | ACELYRIN INC | -- | $25,299.73 | 5,711 | BQPF874 |
| 0.03% | ARCT | ARCTURUS THERAPEUTICS HOLDIN | -- | $25,014.99 | 1,547 | BKC9SX3 |
| 0.03% | TNGX | TANGO THERAPEUTICS INC | -- | $25,014.48 | 6,131 | BP2P6L0 |
| 0.03% | FDMT | 4D MOLECULAR THERAPEUTICS IN | -- | $25,011.34 | 2,974 | BKLXFX5 |
| 0.03% | ALLO | ALLOGENE THERAPEUTICS INC | -- | $24,534.40 | 11,968 | BFZNYB7 |
| 0.03% | TSHA | TAYSHA GENE THERAPIES INC | -- | $23,575.29 | 11,729 | BNC1BX1 |
| 0.03% | RVNC | REVANCE THERAPEUTICS INC | -- | $22,796.20 | 5,999 | BJFSR99 |
| 0.03% | TERN | TERNS PHARMACEUTICALS INC | -- | $22,545.60 | 4,026 | BMDJ0C9 |
| 0.03% | KALV | KALVISTA PHARMACEUTICALS INC | -- | $22,086.40 | 2,465 | BD06CS0 |
| 0.03% | VERV | VERVE THERAPEUTICS INC | -- | $22,026.55 | 4,841 | BNKGXX2 |
| 0.03% | MXCT | MAXCYTE INC | -- | $20,992.35 | 6,015 | BKMQF66 |
| 0.03% | PRME | PRIME MEDICINE INC | -- | $20,538.31 | 6,869 | BPBJFM7 |
| 0.03% | AMLX | AMYLYX PHARMACEUTICALS INC | -- | $20,381.31 | 3,897 | BPCK358 |
| 0.03% | ALEC | ALECTOR INC | -- | $20,232.41 | 5,566 | BJ4LDC4 |
| 0.03% | ACIU | AC IMMUNE SA | -- | $18,322.20 | 5,655 | BZC0D70 |
| 0.02% | SAGE | SAGE THERAPEUTICS INC | -- | $17,155.54 | 3,494 | BP4GNK9 |
| 0.02% | NAUT | NAUTILUS BIOTECHNOLOGY INC | -- | $16,794.18 | 7,177 | BNG1NK8 |
| 0.02% | VYGR | VOYAGER THERAPEUTICS INC | -- | $16,723.20 | 3,120 | BY7RB53 |
| 0.02% | LXRX | LEXICON PHARMACEUTICALS INC | -- | $16,701.88 | 20,686 | BWFZX59 |
| 0.02% | ITOS | ITEOS THERAPEUTICS INC | -- | $16,406.50 | 2,090 | BMWXFT4 |
| 0.02% | VNDA | VANDA PHARMACEUTICALS INC | -- | $16,346.40 | 3,336 | B12W3P6 |
| 0.02% | ACRS | ACLARIS THERAPEUTICS INC | -- | $16,172.64 | 4,084 | BYV2W40 |
| 0.02% | QURE | UNIQURE NV | -- | $15,891.60 | 2,788 | BJFSR88 |
| 0.02% | ATAI | ATAI LIFE SCIENCES NV | -- | $15,270.36 | 9,604 | BN6M8F1 |
| 0.02% | AVIR | ATEA PHARMACEUTICALS INC | -- | $15,256.48 | 4,828 | BLN9Z50 |
| 0.02% | LYEL | LYELL IMMUNOPHARMA INC | -- | $15,090.53 | 14,651 | BN6MB18 |
| 0.02% | PGEN | PRECIGEN INC | -- | $13,777.10 | 16,466 | BKM5C84 |
| 0.02% | BMEA | BIOMEA FUSION INC | -- | $12,987.04 | 2,068 | BNKF6N0 |
| 0.02% | ZNTL | ZENTALIS PHARMACEUTICALS INC | -- | $12,739.10 | 4,070 | BMQ5T49 |
| 0.02% | MGNX | MACROGENICS INC | -- | $11,775.20 | 3,590 | BFDV8K0 |
| 0.02% | EDIT | EDITAS MEDICINE INC | -- | $11,377.61 | 4,721 | BZ8FPH3 |
| 0.02% | AMRN | AMARIN CORP PLC -ADR | -- | $11,321.27 | 22,899 | 2301938 |
| 0.01% | FULC | FULCRUM THERAPEUTICS INC | -- | $10,674.30 | 3,570 | BJDX8Z9 |
| 0.01% | CRBU | CARIBOU BIOSCIENCES INC | -- | $10,137.12 | 5,172 | BNYJR68 |
| 0.01% | CHRS | COHERUS BIOSCIENCES INC | -- | $7,250.10 | 6,591 | BRK0149 |
| 0.01% | VTYX | VENTYX BIOSCIENCES INC | -- | $6,955.68 | 4,044 | BMG99Y1 |
| 0.01% | CABA | CABALETTA BIO INC | -- | $6,318.96 | 2,796 | BK5MWR1 |
| 0.01% | OVID | OVID THERAPEUTICS INC | -- | $4,223.44 | 4,061 | BYPFK63 |
| 0.01% | ALXO | ALX ONCOLOGY HOLDINGS INC | -- | $3,645.73 | 3,013 | BLN7XQ1 |
| -- | BLUE | BLUEBIRD BIO INC | -- | $3,300.88 | 10,894 | BBFL7S1 |
| -- | OKUR | ONKURE THERAPEUTICS INC-A | -- | $3,088.00 | 193 | BT7KGT6 |
| -- | ME | 23ANDME HOLDING CO -CLASS A | -- | $3,052.35 | 969 | BRK1ZT5 |
| -- | RAPT | RAPT THERAPEUTICS INC | -- | $2,135.72 | 1,996 | BK5T6R0 |
| -- | 2324462D | CARTESIAN THERAPEUTICS-CVR | -- | $1,761.30 | 9,785 | BM9HFX3 |
| -- | MRNS | MARINUS PHARMACEUTICALS INC | -- | $973.97 | 3,152 | BM8MVZ3 |
| -- | -- | TREASURY BILL | -- | $9,982,629.60 | 10,000,000 | BNNRNL0 |
| -- | -- | NET OTHER ASSETS (LIABILITIES) | -- | $8,399,523.10 | 8,399,523 | -- |
Index
as of 9/30/2024
- Total Number of Companies214
- Price/Earnings Ratio--
- Price/Book Ratio4.157
- Dividend Yield ( % )0.88
- Avg. Index Market Capitalization$7.59 billion
About the Index
The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.
Distributions
For
2024
- 2024
- 2023
- 2022
| Ex-Dividend Date | Record Date | Payable Date | Dividend | Long-Term Capital Gain | Short-Term Capital Gain | Return of Capital |
|---|
Portfolio Hedging Series
Part I: The Significance of Portfolio Hedging
Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More